DULUTH, Ga., Oct. 6 /PRNewswire/ — Metametrix Clinical Laboratory (http://www.metametrix.com/), a leader in nutritional and metabolic testing services, announced the introduction of the Vitamin K Assay. This latest testing profile measures a functional marker of Vitamin K, undercarboxylated osteocalcin. As one of the first commercial laboratories to offer this type of vitamin K assessment, Metametrix continues its leadership and innovation.
Vitamin K is a fat-soluble vitamin that functions as a co-factor in the production of blood coagulation factors (in the liver), osteocalcin (in bone), and matrix Gla-protiens (in cartilage and vessel walls) each resulting in the deposition of ionic calcium. Vitamin K deficiency lengthens the time required for blood to clot, increases bone fracture risk, and may lead to calcification of the arteries. Individuals especially at risk for vitamin K deficiency include: those with bone loss or risk of bone loss, those on certain drug therapies, such as warfarin, and those with cardiovascular disease.
From a simple serum collection, vitamin K testing is the latest in a series of “Fat-Soluble Vitamin Profiles” from Metametrix and is available as an add-on to its ION and Cardio/ION Profiles. For a complete list of Metametrix laboratory services and related research, visit the website at: http://www.metametrix.com/ .
Metametrix Clinical Laboratory has specialized in producing innovative, Next Generation Technologies(SM) for measuring nutritional, metabolic, and toxic influences on health for the past 24 years. Metametrix is a leader in providing integrative and functional medicine testing services and education to healthcare professionals worldwide.
Metametrix Clinical Laboratory
CONTACT: Jennifer Gillen, Marketing Manager, of Metametrix ClinicalLaboratory, +1-800-221-4640, [email protected]
Web site: http://www.metametrix.com/
Comments